Review in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Hiroe TobaLaboratory of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.ORCID 0000-0002-3860-805X
Ganesh V HaladeHeart Institute, Division of Cardiovascular Sciences, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.ORCID 0000-0002-5351-9354
Kristine Y DeLeon-PennellDivision of Cardiology, Department of Medicine, School of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.ORCID 0000-0002-9647-6112
Ying Ann ChiaoAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States.ORCID 0000-0002-1256-4335
Andriy YabluchanskiyDepartment of Neurosurgery, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, United States.ORCID 0000-0002-9648-7161
Signe Holm NielsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Upendra ChaliseCardiology Division, Department of Medicine, University of Minnesota, Twin Cities, Minneapolis, Minnesota, United States.ORCID 0000-0002-7798-7697
Mediha Becirovic-AgicDivision of Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Lisandra E de Castro BrazDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, United States.ORCID 0000-0002-0190-8892
Merry L LindseyDepartment of Applied Education, School of Graduate Studies, Meharry Medical College, Nashville, Tennessee, United States.ORCID 0000-0002-4090-0391
Funding
Collagen-derived peptides to target inflammation in myocardial infarctionR01HL152297 · NHLBI · EAST CAROLINA UNIVERSITY · 2023 to 2025
$1.1M
Effects of NAD restoration on neurovascular coupling in community dwelling older adultsR01AG075834 · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2025 to 2025
$643k
Interrogating the role of arachidonic acid metabolism in modulating the tumor immune microenvironment as a novel path to therapeutic interventionU01CA293474 · UNIVERSITY OF SOUTH FLORIDA · 2025 to 2025
$622k
Temporal effects of CD8 T-cells post-MIR01HL173273 · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2025 to 2025
$505k
Short Course In Transferable Skills Training (SHIFT) ProgramR25GM151274 · MEHARRY MEDICAL COLLEGE · 2025 to 2025
$486k
STrengthening Research OpportuNities for Growth at Meharry Medical College (Meharry-STRONG)UC2MD019626 · MEHARRY MEDICAL COLLEGE · 2025 to 2025
$364k
Training Program in Cardiac InnovationT32HL144472 · UNIVERSITY OF MINNESOTA · 2025 to 2025
$176k
American Heart Association (AHA) 25IVPHA1462290American Heart Association (AHA) 966924BLRD VA I01 BX005848HHS | National Institutes of Health (NIH) AG075834HHS | National Institutes of Health (NIH) AG080775HHS | National Institutes of Health (NIH) CA293474HHS | National Institutes of Health (NIH) GM151274HHS | National Institutes of Health (NIH) HL144472HHS | National Institutes of Health (NIH) HL152297HHS | National Institutes of Health (NIH) HL173273HHS | National Institutes of Health (NIH) UC2MD019626NCI NIH HHS U01 CA293474NHLBI NIH HHS R01 HL152297NHLBI NIH HHS R01 HL173273NHLBI NIH HHS T32 HL144472NIA NIH HHS R01 AG075834NIA NIH HHS R21 AG080775NIGMS NIH HHS R25 GM151274NIMHD NIH HHS UC2 MD019626O. E. och Edla Johanssons Vetenskapliga StiftelseOklahoma Center for Adult Stem Cell Research (OCASCR) 241009Stiftelsen Apotekare Hedbergs Fond för Medicinsk Forskning (Stiftelsen Apotekare Hedbergs Fond)Stiftelsen Lars Hiertas Minne (Lars Hierta Memorial Foundation) FO2023-0505Takeda Science Foundation (TSF) 2022060878U.S. Department of Veterans Affairs (VA) BX00584U.S. Department of Veterans Affairs (VA) CX002780
6 · The paper itself
Abstract
Wound healing after myocardial infarction (MI) is a dynamic and multifaceted process that links the molecular alterations induced by or in response to prolonged ischemia with structural and physiological changes to the damaged myocardium. Changes, at the tissue level, are driven by a complex intersection of cellular and molecular mechanisms that operate along a classic wound healing paradigm as an attempt to repair the damaged myocardium and restore cardiac physiology. Maladaptive healing prevents a return to the original homeostasis, rather yielding a myocardium reset to a new homeostatic status that can lead to heart failure due to compromised contractility, increased chamber dilation, and cardiac fibrosis or due to sudden cardiac death resulting from arrhythmias. This review summarizes our current knowledge of how key inflammatory drivers in the myocardium (cardiomyocytes, neutrophils, monocytes/macrophages, fibroblasts, and vascular endothelial cells) respond to molecular signals including cytokines, growth factors, and proteases to coordinate the wound healing process in the mouse model of MI. We also identify knowledge gaps that remain in our understanding of cardiac remodeling that are opportunities for future examinations.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Cellular and molecular signals of cardiac wound healing after myocardial infarction. · full record | Socratic